IL17A and atherosclerosis: Interleukin-36 (IL-36) is increasingly recognized as a pivotal trigger in the production of interleukin-17A (IL-17A) within the skin [70,74,75], which in turn plays a crucial role in the development of atherosclerosis, a major contributor to cardiovascular disease [76,77].